98-92-0 | Sigma-Aldrich

The Effective Use of Protein Kinase Inhibitors

94 139 92 92 107 85 85 89 90 114 113 90 107 102 97 98 107 JNK1α1/SAPK1c 97 98 96 49 104 96 102 111 101 93 97 108 101 98 92 89 95 91 100 JNK/SAPK1c

The Effective Use of Protein Kinase Inhibitors

94 139 92 92 107 85 85 89 90 114 113 90 107 102 97 98 107 JNK1α1/SAPK1c 97 98 96 49 104 96 102 111 101 93 97 108 101 98 92 89 95 91 100 JNK/SAPK1c

Poster: Purification with Millipore MultiScreen 384SEQ Plates on Beckman-Coulter’s Biomek FX for High Quality Direct Sequencing in High-Throughput Genomics

336.82 98% il12a_1 yq 37.48 371.95 98% il12a_1 yq 37.44 365.39 93% il12a_1 zq 39.78 400.66 98% il12a_1 zq 41.14 383.16 88% il12a_1 zq 44.93 452.26 98% il12a_7-A yq r1 15.65 0 0% il12a_7-A yq r1 0 0 0% il12a

Scalability of Mobius®Single-Use Bioreactors

90 91 92 93 94 95 96 97 98 99 100 0 2 4 6 8 10 12 % V ia bi lit y V ia bl e

MILLIPLEX®MAP Human Myokine Panel is an optimized quantitative immunoassay that simultaneously measures 15 novel muscle-secreted factors

97 105 119 84 100 82 106 +std 4 92 104 113 77 90 101 105 128 93 115 114 77 130 92 109 +std 5 85 94 135 72 75 101 99 150 90 99 97 72

Application Note – N-Boc deprotection

O 92% 93% 92% HN NH S O H N O O O NH2 98% N H OH NH2 98% 90% NH 91% O O NH3

LABORATORY NOTEBOOK ISSUANCE PAGE

tg en iu m 10 .8 1 12 .0 11 14 .0 07 15 .9 99 18 .9 98 20 .1 80 4. 00 26 26 .9 82 28 .0 85 30 .9 74 32 .0 6 35 .4

LABORATORY NOTEBOOK ISSUANCE PAGE

tg en iu m 10 .8 1 12 .0 11 14 .0 07 15 .9 99 18 .9 98 20 .1 80 4. 00 26 26 .9 82 28 .0 85 30 .9 74 32 .0 6 35 .4

LABORATORY NOTEBOOK ISSUANCE PAGE

tg en iu m 10 .8 1 12 .0 11 14 .0 07 15 .9 99 18 .9 98 20 .1 80 4. 00 26 26 .9 82 28 .0 85 30 .9 74 32 .0 6 35 .4

High throughput sample preparation for the quantitation of drug compounds in serum samples

Digoxin 93±3% 96±2% 98±3% 94±1% Propranolol 97±2% 98±4% 95±3% 96±2% Taxol 93±3% 92±1% 91±2% 88±2% Testosterone 94±3% 92±2% 91±2% 90±1% Verapamil 95±3% 97±1% 92±2% 98±1% Warfarin 91±3% 93±2%

Dental Application Brochure

128-37-0 Platinum (0)-1, 3-divinyl-1, 1, 3, 3-tetramethyldisiloxane complex solution Catalyst; hydrosilylation 68478-92-2 Triphenylphosphine Photo initiator; precursor 603-35-0 Monomer

TC RNA Phosphoramidites

90% 92% 94% 96% 98% 100% DMT-rUtc-AM DMT-rG(ib)tc-AM DMT-rC(ac)tc-AM DMT-rA(bz)tc-AM HPLC Purity Stability in Toluene/Acetonitrile 1:1 / 7 d at 25 ºC 90% 92% 94% 96% 98% 100%

Protocol: Rat/Mouse Ghrelin (Active)

Rat 0 (Basal) 168 -- 181 -- 50 218 100% 233 104% 200 356

Verfication summary-03-0202-00

64.20 6.5 10% 128.41 6.5 5% - 3 1:4 31.31 0.7 2% 125.23 0.7 1% 98% 3 1:8 17.04 0.1 1% 136.34 0.1 0% 106% 3 1:16 7.85 0.3 4% 125.62 0.3 0% 98% HMN108002 3

Verfication summary-03-0202-00

64.20 6.5 10% 128.41 6.5 5% - 3 1:4 31.31 0.7 2% 125.23 0.7 1% 98% 3 1:8 17.04 0.1 1% 136.34 0.1 0% 106% 3 1:16 7.85 0.3 4% 125.62 0.3 0% 98% HMN108002 3

Specialty Materials For Dental Applications Brochure

128-37-0 Platinum (0)-1, 3-divinyl-1, 1, 3, 3-tetramethyldisiloxane complex solution Catalyst; hydrosilylation 68478-92-2 Triphenylphosphine Photo initiator; precursor 603-35-0 Monomer

Testing Lab & Industrial Flyer

for microscopy (Bot., Fl., Hist.) 92-32-0 Analytical 22680 Quinoline Yellow for microscopy (Hist.), mixture of mono- and disulfonic acid sodium salt 8004-92-0 Analytical 84071 Ruthenium Red for

Data Sheet - R5635

1. Wabon, R., et al., FEBS Letters, 118, 47 (1980). 2. Kessler, C., et al., Gene, 92, 1 (1990). 7/98 Sigma brand products are sold

Product Information Sheet - MAK395

Chromophore (nmol/well) 1 0 L 100 L 0 2 2 L 98 L 2 3 4 L 96 L 4 4 6 L 94 L 6 5 8 L 92 L 8 6 10 L 90 L 10

mAb Aggregate Removal Using Flow Through Chromatography on Fractogel®EMD Resin

90% 91% 92% 93% M on om er P u ri ty R ec ov er y of L oa d Antibody in Pool (mg) Bind & Elute Analysis 94%

Product Information Sheet - Amine-Stabilized Borane-Tetrahydrofuran Solutions

%) Temp.(CO) 17,619-2 NaBH 4 98 93.6 5 65,039-0 PMP 97 94.9 5 65,041-2 NIMBA 98 94.8 5 17,619-2 NaBH 4 97 90.3 25 65,039-0 PMP 98 96.1 25 65,041-2 NIMBA 98 96.2 25 Cat. No. (1.0M BH 3

Product Information Sheet - I4507

preservative at 0-8°C. REFERENCES: 1. Sigma production. 2. Methods in Enzymology, 184, 167 (1990). Iminobiotin affinity columns. 3. Heney, G. and Orr, G.A., Anal. Biochem., 114, 92-96 (1981). Purification

Data Sheet - A5156

actinomycin D (98% purity) and 49 mg of Mannitol. It is soluble in water at 20 mg/ml. References 1. Merck Index, 12th ed., No. 2867 (1996). 2. Meienhofer, J., J. Am. Chem. Soc., 92, 3771-77 (

Data Sheet - A1410

actinomycin D (98% purity) and 49 mg of Mannitol. It is soluble in water at 20 mg/ml. References 1. Merck Index, 12th ed., No. 2867 (1996). 2. Meienhofer, J., J. Am. Chem. Soc., 92, 3771-77 (

Data Sheet - A4262

actinomycin D (98% purity) and 49 mg of Mannitol. It is soluble in water at 20 mg/ml. References 1. Merck Index, 12th ed., No. 2867 (1996). 2. Meienhofer, J., J. Am. Chem. Soc., 92, 3771-77 (

Actinomycin D (A9415)

actinomycin D (98% purity) and 49 mg of Mannitol. It is soluble in water at 20 mg/ml. References 1. Merck Index, 12th ed., No. 2867 (1996). 2. Meienhofer, J., J. Am. Chem. Soc., 92, 3771-77 (

Protocol- EZRGRA-90K

1,000 1,070 90% 973 87% Rat 0 (Basal) 168 -- 181 - 50 218 100% 233 104% 200 356 94% 374 97% 1,000 1,070 90% 1,100 92% Mouse 0 (Basal)

Predictable Protection and Performance

Each lot was tested in triplicate. Figure 2. Quality Grade Benchmark 80 82 84 86 88 90 92 94 96 98 100 0 1 2 3 4 Quality Grade Benchmark Competitor A2 Standard Grade (3 lots) Competitor A2

SARS-Cov2 anti-RBD IgG ELISA

Expected (ng/mL) Observed (ng/mL) Expected 1 100 29.1 29.1 50 14.6 14.2 98% 25 7.3 6.7 92% 12.5 3.6 3.3 90%

Protocol: Human PYY (Total) ELISA Kit - 96-Well Plate

97% 500 511 84% 647 109% F 0 (Basal) 75 -- 78 -- 40 115 100% 114 90% 100 167 92% 167